Viewing StudyNCT04969731



Ignite Creation Date: 2024-05-06 @ 4:23 PM
Last Modification Date: 2024-10-26 @ 2:09 PM
Study NCT ID: NCT04969731
Status: RECRUITING
Last Update Posted: 2021-11-22
First Post: 2021-07-06

Brief Title: Safety and Efficacy of Immuncell-LC With Gemcitabine in Resectable Pancreatic Cancer
Sponsor: GC Cell Corporation
Organization: GC Cell Corporation

Conditions & Keywords Data

Conditions:
Name
Pancreatic Ductal Adenocarcinoma
Keywords:
Name View
Pancreatic Cancer View
Adjuvant Therapy View
Immuncell-LC View
Gemcitabine View
ILC-P3-PAN View